Jose Carmona - 13 Feb 2026 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role: Chief Financial Officer
Signature: /s/ Lisa Kallebo, Attorney-in-Fact for Jose Carmona
Issuer symbol: ADCT
Transactions as of: 13 Feb 2026
Net transactions value: +$980,423
Form type: 4
Filing time: 18 Feb 2026, 17:42:53 UTC
Previous filing: 09 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Carmona Jose	Chief Financial Officer	430 MOUNTAIN AVENUE, SUITE 404, NEW PROVIDENCE	/s/ Lisa Kallebo, Attorney-in-Fact for Jose Carmona	18 Feb 2026	0001693612

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADCT	Common Shares	Award	$1,083,684	+271,600	+56%	$3.99	760,256	13 Feb 2026	Direct	F1
transaction	ADCT	Common Shares	Tax liability	$103,261	-25,880	-3.4%	$3.99	734,376	13 Feb 2026	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2026, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event.
F2	Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.